The secondary cascade, although a normal physiological response, can contribute to ongoing neuroinflammation, oxidative stress and axonal ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.

ITCHY eyes, constant sneezing, a runny nose… all signs hay fever season is well and truly here. Yep, that joyous time of the year when one in four Brits dreads the smell of freshly-cut grass ...

Promising review: "Amazing! When my allergies get me feeling bogged down, I take this and feel relief within minutes. Even ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

This condition occurs when the nasal passages become dependent on the spray to remain open, leading to a vicious cycle of usage and worsening symptoms. Frequent and prolonged use of decongestants can ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that ...